(4-Bromo-2,5-dimethoxyphenyl)boronic acid, 95.0%, 250mg

2-Bromo-4-fluoroaniline>98.0%(GC)5g

(3R,5S,6E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[(METHANESULFONYL) METHYLAMINO]PYRIMIDIN-5-YL]-3,5-DIHYDROXYHEPT-6-ENOIC ACID TERT-BUTYL ESTER, 95%, 25g

(3-methyl-2-oxo-1-imidazolidinyl)acetic acid, 95.0%, 1g

2-Ethyl-1,3-hexanediol (mixture of diastereoisomers)25mL

Benzyl 3-(benzylamino)piperidine-1-carboxylate hydrochloride, 95%, 250mg

Tris(3-bromophenyl)phosphine Oxide>98.0%(GC)1g

Balance d'analyse et de précision Série Entris® II Modèles avec réglage interne, non certifiée, 0,01 g, 820 g, BCE822i-1S

N-(4-bromophenyl)-4-nitrobenzenesulfonamide, 95%, 5g

(1S)-(+)-Camphorquinone>97.0%(GC)1g

(S)-2-Amino-2-(4,4-difluorocyclohexyl)acetic acid hydrochloride, 98%, 100mg

Methyl 5-hydroxy-6-methoxynicotinate, 95.0%, 25g

Flacon d'application de sécurité, 180 ml, 1 pièce